Kestra Medical Technologies (KMTS) Proxy Filing summary

Executive summary

• The 2025 Annual General Meeting will be held virtually on September 3, 2025, with shareholders able to vote and submit questions online.

• Shareholders will vote on electing two Class I directors, ratifying the external auditor, and approving the 2025 Employee Stock Purchase Plan (ESPP).

• The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.

• Audited financial statements for the year ended April 30, 2025, will be presented at the meeting.

Voting matters and shareholder proposals

• Proposals include electing Conor Hanley and Elizabeth Kwo as Class I directors, ratifying PricewaterhouseCoopers LLP as auditor, and approving the ESPP.

• Shareholders of record as of July 7, 2025, are eligible to vote.

• Board recommends voting FOR all proposals.

• Shareholder proposals for the 2026 meeting must be submitted by March 24, 2026, for inclusion in proxy materials.

Board of directors and corporate governance

• The Board will reduce its size after the meeting due to three directors not standing for re-election.

• Board committees include audit, compensation, and nominating/governance, all composed of independent directors.

• The Board is led by an independent chairman, with regular executive sessions for independent directors.

• Corporate governance guidelines and a Code of Conduct are in place, with policies for director independence and diversity.